DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sandostatin (Octreotide) - Blood Pressure Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Blood Pressure Increased (48)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) where reactions include blood pressure increased. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 48   Next >>

Possible Sandostatin side effects in male

Reported by a consumer/non-health professional from Canada on 2012-08-16

Patient: male

Reactions: Jaundice, Abdominal Pain, Blood Bilirubin Increased, Confusional State, Agitation, Weight Decreased, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Malaise, Fatigue, Pleural Effusion, Cardiac Failure Congestive, Cough, Decreased Appetite, Lethargy, Blood Pressure Increased, Dyspnoea, Restlessness, Pain in Extremity, Ascites, Discomfort, Heart Rate Decreased, Abdominal Mass, Syncope, Micturition Disorder, Joint Swelling, Urine Colour Abnormal, Dehydration, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 30 mg, every 3 weeks

Sandostatin

Sandostatin LAR
    Dosage: 20 mg, once in a month
    Indication: Neuroendocrine Tumour
    Start date: 2011-02-28

Other drugs received by patient: Sutent



Possible Sandostatin side effects in female

Reported by a physician from Canada on 2012-08-16

Patient: female

Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Thermal Burn, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21

Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, qmo



Possible Sandostatin side effects in male

Reported by a consumer/non-health professional from Canada on 2012-08-06

Patient: male

Reactions: Blood Bilirubin Increased, Confusional State, Weight Decreased, Abdominal Pain, Agitation, Jaundice, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Fatigue, Malaise, Pleural Effusion, Cough, Decreased Appetite, Lethargy, Cardiac Failure Congestive, Blood Pressure Increased, Dyspnoea, Pain in Extremity, Restlessness, Discomfort, Ascites, Syncope, Abdominal Mass, Heart Rate Decreased, Joint Swelling, Micturition Disorder, Urine Colour Abnormal, Dehydration, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin

Sandostatin LAR
    Dosage: 20 mg, once in a month
    Indication: Neuroendocrine Tumour
    Start date: 2011-02-28

Sandostatin LAR
    Dosage: 30 mg, every 3 weeks

Other drugs received by patient: Sutent



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-23

Patient: female

Reactions: Blood Pressure Increased, Urinary Tract Infection, Chromaturia, Bladder Pain, Cystitis, Female Genital Tract Fistula, Oropharyngeal Pain, Stress, Abdominal Discomfort, Staphylococcal Infection, Dysuria, Blood Pressure Fluctuation, Kidney Infection, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Indication: Short-Bowel Syndrome

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks

Sandostatin LAR
    Dosage: 20 mg, qmo
    Indication: Short-Bowel Syndrome
    Start date: 2009-12-22

Sandostatin LAR
    Dosage: 40 mg, qmo

Sandostatin LAR
    Dosage: 10 mg, qmo



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-20

Patient: female

Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Asthenia, Thermal Burn, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21

Sandostatin LAR
    Dosage: 20 mg, qmo



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-07-17

Patient: female

Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Dizziness, Abdominal Distension, Anuria, Blood Pressure Increased, Back Pain, Humerus Fracture, Gastrointestinal Motility Disorder, Vomiting, Pain in Extremity, Nausea, Flushing, Arthralgia, Diarrhoea, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 30 mg, qmo

Sandostatin
    Dosage: 100 ug, tid
    Indication: Small Intestine Carcinoma

Sandostatin LAR
    Dosage: 30 mg, qmo

Sandostatin LAR
    Dosage: 30 mg, tiw
    Indication: Small Intestine Carcinoma
    Start date: 2009-05-26

Sandostatin LAR
    Dosage: 30 mg, tiw

Sandostatin LAR
    Dosage: 30 mg, tiw

Other drugs received by patient: Xeloda; Capecitabine



Possible Sandostatin side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female

Reactions: Blood Pressure Increased, Soft Tissue Mass, Gallbladder Disorder, Blood Pressure Decreased, Feeling Abnormal

Drug(s) suspected as cause:
Sandostatin

Other drugs received by patient: Synthroid; M.v.i.; Ascorbic Acid; Hydrochlorothiazide



Possible Sandostatin side effects in female

Reported by a physician from Canada on 2012-06-28

Patient: female

Reactions: Abdominal Pain, Blood Pressure Increased, Blood Growth Hormone Increased, Mass, Blood Pressure Systolic Increased, Necrosis, Acne, Loss of Consciousness, Abdominal Pain Upper, Fatigue, Injection Site Calcification, Arthralgia, Dizziness, Asthenia

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 40 mg every 3 weeks
    Indication: Acromegaly
    Start date: 2004-07-15

Sandostatin
    Dosage: 3 df, (3 times per night)
    Indication: Headache

Other drugs received by patient: Avalide



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-06-25

Patient: female

Reactions: Blood Pressure Increased, Poor Quality Sleep, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Thermal Burn, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, qmo



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-25

Patient: female

Reactions: Blood Pressure Increased, Visual Impairment, Coagulopathy

Drug(s) suspected as cause:
Sandostatin
    Dosage: unk ukn, once/single
    Indication: Acromegaly
    Start date: 2012-04-19
    End date: 2012-04-19

Sandostatin LAR
    Dosage: 20 mg, qmo
    Indication: Acromegaly
    Start date: 2012-04-20
    End date: 2012-05-18



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-06-13

Patient: female

Reactions: Blood Pressure Increased, Coagulopathy, Visual Impairment

Drug(s) suspected as cause:
Sandostatin
    Dosage: unk ukn, once/single
    Indication: Acromegaly
    Start date: 2012-04-19
    End date: 2012-04-19

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Acromegaly
    Start date: 2012-04-20



Possible Sandostatin side effects in male

Reported by a consumer/non-health professional from Canada on 2012-06-01

Patient: male

Reactions: Weight Decreased, Blood Pressure Increased, Flank Pain, Heart Rate Irregular, Depressed Mood

Drug(s) suspected as cause:
Sandostatin



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-25

Patient: female

Reactions: Back Pain, Blood Pressure Increased, Abdominal Pain, Renal Disorder, Pain, Breakthrough Pain, Injection Site Pain, Laceration, Neoplasm Progression, Fall, Dysgeusia, Malaise, Spinal Compression Fracture, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every four weeks
    End date: 2012-02-22

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks

Sandostatin
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-01-20
    End date: 2011-01-23

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-01-24

Other drugs received by patient: Fentanyl-100; Dexamethasone; Dilaudid



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-24

Patient: female

Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Asthenia, Thermal Burn, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-22

Patient: female

Reactions: Blood Pressure Increased, Back Pain, Abdominal Pain, Renal Disorder, Pain, Injection Site Pain, Laceration, Breakthrough Pain, Fall, Dysgeusia, Malaise, Spinal Compression Fracture, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-01-24

Sandostatin
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-01-20
    End date: 2011-01-23

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks

Sandostatin LAR
    Dosage: 20 mg, every four weeks

Other drugs received by patient: Dexamethasone; Dilaudid; Fentanyl-100



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-05-22

Patient: female

Reactions: Blood Pressure Increased, Coagulopathy, Visual Impairment

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Acromegaly
    Start date: 2012-04-20

Sandostatin
    Dosage: unk ukn, once/single
    Indication: Acromegaly
    Start date: 2012-04-19
    End date: 2012-04-19



Possible Sandostatin side effects in female

Reported by a physician from Canada on 2012-05-14

Patient: female

Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Abdominal Distension, Dizziness, Back Pain, Blood Pressure Increased, Humerus Fracture, Vomiting, Nausea, Pain in Extremity, Flushing, Diarrhoea, Arthralgia, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 30 mg, qmo

Sandostatin LAR
    Dosage: 30 mg, every 3 weeks

Sandostatin LAR
    Dosage: 30 mg, qmo

Sandostatin
    Dosage: 100 ug, tid
    Indication: Small Intestine Carcinoma

Sandostatin LAR
    Dosage: 30 mg, tiw
    Indication: Small Intestine Carcinoma
    Start date: 2009-05-26

Sandostatin LAR
    Dosage: 30 mg, every three weeks

Other drugs received by patient: Xeloda; Capecitabine



Possible Sandostatin side effects in female

Reported by a physician from Canada on 2012-04-30

Patient: female

Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21

Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg every 4 weeks



Possible Sandostatin side effects in female

Reported by a physician from Canada on 2012-04-05

Patient: female

Reactions: Abdominal Pain, Pedal Pulse Abnormal, Loss of Consciousness, Malaise, Psychiatric Symptom, Epistaxis, Back Pain, Visual Field Defect, Pain in Extremity, Anaemia, Hypotension, General Physical Health Deterioration, Stress, Abdominal Pain Upper, Speech Disorder, Myalgia, Fatigue, Transient Ischaemic Attack, Blood Sodium Decreased, Blood Pressure Increased, Vomiting, Nausea, Muscular Weakness, Injection Site Pain, Cerebrovascular Accident, Diarrhoea, Arthralgia, Hypophagia, Memory Impairment, Gait Disturbance, Asthenia, Feeling Abnormal, Influenza

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, every 3 weeks
    Start date: 2010-06-02

Sandostatin
    Dosage: 20 mg, bid

Sandostatin LAR
    Dosage: 20 mg, qmo
    End date: 2011-04-05

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Neuroendocrine Tumour
    Start date: 2007-08-24
    End date: 2011-04-05

Sandostatin
    Indication: Neuroendocrine Tumour

Other drugs received by patient: Ferrous Sulfate TAB; Calcium with Vitamin D; Swine FLU Vaccine, Monovalent; Asaphen; Novo-Venlafaxine; Metformin HCL; Novo-Loperamide; Cyproheptadine HCL; Senntab; Novo-Pantoprazole; Novo-Docusate; Synthroid; Oxazepam



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-04-02

Patient: female

Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg every 4 weeks

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-03-19

Patient: female

Reactions: Blood Pressure Increased, Back Pain, Abdominal Pain, Renal Disorder, Pain, Laceration, Injection Site Pain, Breakthrough Pain, Fall, Dysgeusia, Spinal Compression Fracture, Malaise, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-01-20
    End date: 2011-01-23

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-01-24

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every four weeks

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks

Other drugs received by patient: Dexamethasone; Fentanyl; Dilaudid



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-03-07

Patient: female

Reactions: Blood Pressure Increased, Poor Quality Sleep, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg every 4 weeks

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-03-05

Patient: female

Reactions: Abdominal Pain, Blood Pressure Increased, Back Pain, Renal Disorder, Pain, Breakthrough Pain, Injection Site Pain, Laceration, Fall, Dysgeusia, Spinal Compression Fracture, Malaise, Neoplasm Malignant, Dehydration, Oedema, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks

Sandostatin
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-01-20
    End date: 2011-01-23

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-01-24

Sandostatin LAR
    Dosage: 20 mg, qmo

Other drugs received by patient: Dexamethasone; Dilaudid; Fentanyl



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-02-13

Patient: female

Reactions: Abdominal Pain, Pedal Pulse Abnormal, Loss of Consciousness, Malaise, Psychiatric Symptom, Epistaxis, Back Pain, Visual Field Defect, Pain in Extremity, Hypotension, Anaemia, General Physical Health Deterioration, Stress, Abdominal Pain Upper, Speech Disorder, Myalgia, Fatigue, Blood Sodium Decreased, Transient Ischaemic Attack, Blood Pressure Increased, Vomiting, Nausea, Injection Site Pain, Muscular Weakness, Cerebrovascular Accident, Diarrhoea, Arthralgia, Hypophagia, Memory Impairment, Gait Disturbance, Asthenia, Feeling Abnormal, Influenza

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Indication: Neuroendocrine Tumour

Sandostatin
    Dosage: 20 mg, bid

Sandostatin LAR
    Dosage: 20 mg, every 3 weeks
    Start date: 2010-06-02

Sandostatin LAR
    Dosage: 20 mg, qmo
    End date: 2011-04-05

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Neuroendocrine Tumour
    Start date: 2007-08-24
    End date: 2011-04-05

Other drugs received by patient: Novo-Pantoprazole; Swine FLU Vaccine, Monovalent; Metformin HCL; Oxazepam; Novo-Loperamide; Novo-Docusate; Cyproheptadine HCL; Senntab; Ferrous Sulfate TAB; Asaphen; Novo-Venlafaxine; Calcium with Vitamin D; Synthroid



Possible Sandostatin side effects in female

Reported by a physician from Canada on 2012-02-06

Patient: female

Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg every 4 weeks

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21



Possible Sandostatin side effects in male

Reported by a physician from Canada on 2012-02-06

Patient: male

Reactions: Blood Pressure Increased, Feeling Abnormal, Muscle Mass

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, tid
    Indication: Pituitary Tumour Benign
    Start date: 2010-09-03

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg every 4 weeks

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, qmo
    Indication: Pituitary Tumour Benign
    Start date: 2010-09-12

Sandostatin LAR
    Dosage: 10 mg, every four weeks



Possible Sandostatin side effects in female

Reported by a physician from Canada on 2012-01-31

Patient: female

Reactions: Abdominal Pain, Flatulence, Pain, Fall, Constipation, Abdominal Pain Upper, Herpes Zoster, Malaise, Fatigue, Abdominal Distension, Dizziness, Back Pain, Blood Pressure Increased, Humerus Fracture, Vomiting, Pain in Extremity, Nausea, Flushing, Diarrhoea, Arthralgia, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 30 mg, every 3 weeks

Sandostatin LAR
    Dosage: 30 mg every 3 weeks
    Indication: Carcinoid Tumour of THE Stomach
    Start date: 2009-05-26

Sandostatin LAR
    Dosage: 30 mg, tiw

Sandostatin
    Dosage: 100 ug, tid
    Indication: Carcinoid Tumour of THE Gastrointestinal Tract

Sandostatin LAR
    Dosage: 30 mg, qmo

Sandostatin LAR
    Dosage: 30 mg, qmo

Sandostatin LAR
    Dosage: 30 mg, every three weeks

Other drugs received by patient: Capecitabine; Xeloda



Possible Sandostatin side effects in female

Reported by a individual with unspecified qualification from Canada on 2012-01-11

Patient: female

Reactions: Blood Pressure Increased, Nausea, Injection Site Reaction, Wheezing, Abnormal Sensation in Eye, Vision Blurred, Bronchitis, Memory Impairment, Constipation

Drug(s) suspected as cause:
Sandostatin



Possible Sandostatin side effects in female

Reported by a individual with unspecified qualification from Canada on 2012-01-09

Patient: female

Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg every 4 weeks

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21



Possible Sandostatin side effects in male

Reported by a individual with unspecified qualification from Canada on 2012-01-04

Patient: male

Reactions: Blood Pressure Increased, Feeling Abnormal

Drug(s) suspected as cause:
Sandostatin LAR
    Dosage: 10 mg, every four weeks

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, qmo
    Indication: Pituitary Tumour Benign
    Start date: 2010-09-12

Sandostatin
    Dosage: 50 ug, tid
    Indication: Pituitary Tumour Benign
    Start date: 2010-09-03

Sandostatin LAR
    Dosage: 20 mg every 4 weeks

Sandostatin LAR
    Dosage: 20 mg, qmo



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017